Colorectal cancer (CRC) is one of the most prevalent cancers worldwide, and an ideal target for early detection and prevention through cancer screening. Unfortunately, rates of participation in screening are less than adequate. In this article we explore why people who were offered a fecal immunochemical test for CRC decided to participate or not, and for those who did participate, what influenced them to take action and complete the test. We conducted four focus groups and 30 telephone interviews with 63 people. The main reason people decided to screen was "wanting to know" their CRC status, which operated on a continuum ranging from wanting to know, through varying degrees of ambivalence, to not wanting to know. The majority of participants expressed ambivalence about CRC screening, and the main cue to action was the opportunity to screen without being too inconvenienced.
Colorectal cancer (CRC) is a significant global health problem; it is one of the most prevalent cancers worldwide. In developed countries, it is the third most commonly diagnosed cancer in men and the second in women (Jemal et al., 2011) . In Australia, CRC is the second most commonly diagnosed cancer in both men and women, although men have higher rates of incidence than women (Australian Institute of Health & Welfare [AIHW], 2008) . It is also the second most common cause of cancer-related death in Australia (AIHW, 2012) . The incidence of CRC increases with age; around 93% of people diagnosed in Australia are aged 50 or older (AIHW, 2012) .
Screening is an effective means of reducing the incidence of death from CRC (AIHW, 2012) , and populationbased bowel cancer screening has been introduced in a number of countries (Benson et al., 2008) . In the Australian context, as in many countries, screening begins with testing a sample of feces for minute traces of blood, which is an indication of CRC risk but can be caused by other factors. The test does not detect CRC itself, and individuals returning a positive screen are then referred for diagnostic evaluation, usually by colonoscopy.
The most recent Cochrane systematic review of CRC screening reported an overall reduction in mortality of approximately 25% (adjusting for nonattendance to screening). It also reported a false-positive rate of approximately 80%, which can lead to adverse psychosocial and physiological consequences (Hewitson, Glasziou, Watson, Towler, & Irwig, 2008) . The review included studies using fecal occult blood test (FOBT) technology to test for CRC risk, and the authors concluded that the results "provide further support for the use of FOBT as a population-screening modality to reduce CRC mortality" (p. 1546).
In Australia, the National Bowel Cancer Screening Program (NBCSP) was introduced in 2006 with the aim of reducing the incidence and mortality rate of CRC. The program uses a fecal immunochemical test (FIT) to detect occult blood (AIHW, 2012) . FIT is now the preferred FOBT technology because of its superior acceptability and capacity to detect cancer (Young, 2009) . Currently, the NBCSP sends FIT kits to people turning 50, 55, 60, 65, and 70 years old, although at the time of the study, kits were sent only to those turning 50, 55, and 65. The test is completed at home and posted to a central pathology laboratory for analysis.
Screening participation rates through the NBCSP are lower than ideal, with the most recent figures for participation, from July 2008 to June 2011 (Phase 2), being 38.4% (AIHW, 2012) . Issues with uptake have also been reported in other countries (Levin et al., 2011) . Therefore, it is important to understand how people decide whether or not to participate in CRC screening, and what influences them to take action.
Literature Review
Previous research explored people's knowledge of and attitudes toward CRC, as well as facilitators and barriers to screening. Quantitative research in this area identified a range of demographic characteristics associated with screening for CRC, including gender, age, socioeconomic status, and ethnicity Vernon, 1997; Ward et al., 2010) , in addition to knowledge of and attitudes toward CRC and screening Janz et al., 2007; Vernon) . Health motivation has also been reported as a significant influence on the decision to screen for CRC (Gregory et al.; Vernon) . In a review of the literature by Vernon, the author identified that health motivation, or a preventive health orientation (illustrated in engagement in other forms of health promotion), was consistently positively associated with screening and was a differentiating factor between persistent compliance with screening and persistent refusal.
Risk perception has been found in some studies to influence the decision to screen for CRC (Vernon, 1997) . For example, Lipkus, Lyna, and Rimer (2000) found that baseline absolute risk did not predict screening intentions, whereas greater perceived absolute risk, comparative risk, and concerns at follow-up were predictive of thinking about, or planning to get, an FOBT. Paradoxically, in The UK CRC Screening Pilot Evaluation Team's (2003) evaluation study, perceived susceptibility was not found to be associated with screening. Similar results were reported by Madlensky, Esplen, Gallinger, McLaughlin, and Goel (2003) . Other influential variables include knowing someone with cancer or CRC (Vernon) , provider recommendation, and family history of CRC (Costanza et al., 2005) .
A number of barriers to CRC screening have also been identified, including individual barriers, provider barriers, and system barriers (Walsh, 2005) . Individual barriers include lack of knowledge about CRC and screening, negative attitudes toward screening (Janz et al., 2007; , procrastination (Janz et al.; Vernon, 1997; Worthley et al., 2006) , lack of perceived susceptibility (Vernon; Worthley et al.) , fear of having cancer or not wanting to know about health problems (Arveux et al, 1992; Vernon) , and procedural barriers such as possible embarrassment, pain, discomfort, and the perceived unpleasantness of the test Janz et al.; Vernon) . Procedural barriers were identified in the UK CRC Screening Pilot Evaluation Team's (2003) report as the most significant factor that affects the uptake of CRC screening. An Australian study that analyzed why people refuse screening for CRC also revealed significant individual barriers, including procrastination, unpleasantness of the test, and lack of symptoms (Worthley et al.) .
Research in the United States has identified provider barriers, such as a lack of recommendations or negative attitudes toward CRC screening by health care providers, and system barriers, such as a lack of health care coverage for CRC screening, as major obstacles to the uptake of screening (Costanza et al., 2005; . According to Vedel, Puts, Monette, Monette, and Bergman's (2011) systematic review of the literature (wherein most of the studies were conducted in North America and Europe), the most frequently reported barriers to CRC screening were a lack of provider recommendation, embarrassment, fear and discomfort on the part of the patient, and the lack of health care coverage for screening tests.
Qualitative research has generally supported the quantitative findings on the importance of individual, provider, and system barriers to and facilitators of CRC screening (Brouse et al., 2003; Chapple, Ziebland, Hewitson, & McPherson, 2008; Green et al., 2008; Wackerbarth, Peters, & Haist, 2005; Weitzman, Zapka, Estabrook, & Goins, 2001) . Qualitative research has also revealed barriers to and facilitators of CRC screening not reported in the quantitative literature by delving more deeply into people's experiences and perceptions, and exploring cultural and social aspects of the CRC screening experience. For example, trust (Jones, Devers, Kuzel, & Woolf, 2010; Lasser, Ayanian, Fletcher, & DelVecchio Good, 2008) and being a "good citizen" (Chapple et al.) have been found to influence CRC screening. The influence of culture and gender on screening participation has also been qualitatively explored (Goldman, Diaz, & Kim, 2009; Javanparast, Ward, Carter, & Wilson, 2012; Molina-Barcelo, Salas Trejo, Peiro-Perez, & Malaga Lopez, 2011; Severino, Wilson, Turnbull, Duncan, & Gregory, 2009) .
Despite the growing body of qualitative research in this area, a gap remains in understanding the reasons why some people are able to surmount significant barriers to screening. Another gap in the literature relates to understanding why some people who agree to screen for CRC fail to take action, whereas others follow through on their intentions. Furthermore, much of the existing research was based in the United States, with relatively few Australian studies conducted. This is a significant gap in the literature because of major differences in health care systems between countries, and the effect of these systems on screening participation. In particular, financial concerns have been found to be a major barrier to screening in the United States, whereas Australia's public health care system means that this barrier is unlikely to be significant. There are also differences in the nature of the screening programs offered in different countries.
In this study we aimed to build on existing literature on the decision to screen for CRC and address the gaps identified above. In particular, we explored why people who were offered a FIT decided to screen or not to screen, and what influenced them to take action and complete the test despite the widely documented barriers that affect participation. We separately explored the decision to screen and screening behavior based on research suggesting that there is often a gap between intention and behavior (Webb & Sheeran, 2006) , with intentions explaining, on average, only 28% of the variance in future behavior (Sheeran, 2002) .
Methods
The analysis reported here formed the qualitative aspect of a randomized controlled trial conducted in Australia. The trial tested whether personalized and online decision support, tailored on psychological variables, resulted in better participation in CRC screening than nontailored online and traditional paper-based resources . The participants (N = 3,408) were recruited from a randomly selected sample of men and women identified from the Australian electoral role, and they were randomized to tailored, nontailored, and control groups.
All trial participants completed a baseline survey exploring variables from the Preventive Health Model (Conner & Norman, 1999) , as well as decision stage using the Precaution Adoption Process Model (Weinstein, 1988) . Participants allocated to the tailored group were also given online feedback tailored to their responses. Trial participants were invited to screen for CRC and were sent a FIT by post, accompanied by either paperbased bowel cancer information (control group) or access to information via the online tool. They were asked to complete the FIT within a specified time and send it to a laboratory (using a prepaid postage pack) for analysis. Eligibility criteria for the randomized controlled trial included people aged 50 to 75 years; access to the Internet (because the decision support system was Internet-based); and no undertaking of FIT screening in the preceding 12 months. The age range was selected to reflect the target population for CRC screening.
To explore decision making around CRC screening, we conducted focus groups and interviews with 63 participants from the randomized controlled trial who had been sent a FIT, including 43 screeners and 20 nonscreeners. The term "screeners" is used to describe participants who returned their completed FIT, and "nonscreeners" is used to describe those who failed to return the completed kit within the specified time (12 weeks). The term "participant" refers to participants in the interviews and focus groups. Ethics approval for the trial, including the qualitative component, was sought from and granted by the University of Adelaide Human Research Ethics Committee. Participants were assured of their confidentiality and that no identifying information would be presented in any outcomes of the study.
Recruitment and Sampling Framework
Interview and focus group participants were purposively recruited from participants in the randomized controlled trial and sampled using a maximum-variability sampling framework (Grbich, 1999) . Interview participants were chosen based on a selection matrix that included completion of FIT, gender, and age group. These factors were chosen to ensure that the views of screeners and nonscreeners were included, and that the sample was heterogeneous regarding age and gender. Participants were selected with a view to meeting the recruitment goal of 30 participants.
Focus group participants were recruited to explore their perceptions of the usability and acceptability of the decision support tool. They were chosen based on a selection matrix of randomization, completion of FIT, gender, and age group. Participants were selected with a view to meeting the recruitment goal of 30 participants. We anticipated that we would recruit more screeners than nonscreeners for the interviews and focus groups, because there were fewer nonscreeners in the overall sample of participants in the randomized controlled trial.
Using a list of all participants in the randomized controlled trial, potential participants were telephoned by one of the authors and invited to participate in a focus group or telephone interview. As each selection criterion was met, the list was scanned for the next person who fulfilled an unmet criterion. Sixty-three people agreed to participate (43 screeners, 20 nonscreeners), 30 in the telephone interviews and 33 in the focus groups. Sixty-five people declined to participate, of which 27 (41.5%) were nonscreeners. The main reasons given for refusal were too busy with work and other commitments, illness, and not interested in being involved. Thirty-five men and 28 women agreed to participate. The majority of the participants were aged between 55 and 64 years (56%), with 19% aged 50 to 55 and 25% aged 65 to 70+. The participants were employed full time (37%) or part time (16%), and 43% were retired.
Data Collection
We conducted four focus groups and 30 telephone interviews. Telephone interviews were conducted with 16 screeners and 14 nonscreeners, and 27 screeners and 6 nonscreeners participated in the focus groups. Semistructured interview guides for the telephone and focus group interviews were developed with the aim of exploring the decision to screen or not to screen for CRC. The interview guides focused on the reasons for the decision and the influence of others on the decision. Particular issues explored within these domains were based on the facilitators and barriers identified in previous research, including the perceived efficacy of screening, possible concerns about the test results, procedural barriers regarding the FIT, health perceptions, thoughts on cancer, and perceived risk of cancer. Participants were also asked to discuss any other issues related to CRC, screening, and their decision making, and the open-ended nature of the interview guide encouraged the participants to express their own views and experiences.
Six pilot telephone interviews were conducted to refine the interview guide, and a few minor changes were made before proceeding with data collection; the pilot interviews were included in the analysis. The telephone interviews were conducted between May and June 2011, and the average duration of the interviews was 30 minutes. The interviews were conducted by one of the authors who worked as a project officer on the randomized controlled trial.
A different interview guide was developed for the focus groups to explore in detail the participants' perceptions of the usability and acceptability of the decision support tool (this analysis will be published separately). The focus group guide also incorporated the questions used in the telephone interviews, and these data were included in the analysis presented here. There were 8 participants in Focus Group (FG) 1, 10 in FG 2, 8 in FG 3, and 7 in FG 4. The focus groups were conducted by a research consultant not connected with the study in a consumer testing laboratory at the Commonwealth Scientific and Industrial Research Organisation. Participants were encouraged to discuss issues freely and express divergent views. Issues raised that were not included in the interview guide were pursued. The focus groups took place in September 2011 and were around 2 hours in duration. The focus group participants were compensated for their time and travel (AUS$50).
Data Analysis
The interviews and focus groups were audiotaped and transcribed verbatim. We used a framework analysis approach to analyze the data. Framework analysis is a qualitative analysis method specifically suited to applied research that has specific questions, a limited timeframe, a predesigned sample, and a priori issues to be explored, such as those identified in existing literature (Strivastava & Thomson, 2009) . Framework analysis provides additional capacity to identify and examine emergent themes and ideas (Lipstein et al., 2010; Strivastava & Thomson) .
Framework analysis has previously been used to explore CRC screening (Green et al., 2008) , and the analytic processes are similar to other forms of thematic analysis commonly used in qualitative research in this area (Weitzman et al., 2001) . Framework analysis involves a 5-step process: familiarization with the interviews and transcripts to gain an overview of the data and note key ideas and recurrent themes; identification of a thematic framework using both a priori and new themes arising from the data; indexing, in which portions or sections of the data that correspond to a particular theme are identified; charting, in which indexed pieces of data are arranged in charts of the themes; and mapping and interpretation, which involves analysis of the key characteristics laid out in the charts (Strivastava & Thomson, 2009 ).
Charting is one aspect of framework analysis that is different from other forms of thematic analysis, and it offers important advantages. It involves presenting the data in tables, with the themes on the vertical axis and participants on the horizontal axis. Quotations from the participant interviews were put into the tables under each theme. Charting provides a visual display of the data to facilitate comparisons between participants and the exploration of negative cases, and it ensures that the analysis is based firmly in participants' views. It also provides a transparent means of sharing the data with other researchers for group discussion. The charts form a basis for the final stage of mapping and interpretation, in which the aims are to define concepts, explore and map the range of phenomena, create typologies, find associations, provide explanations, and develop strategies, all of which are grounded in the data and reflective of the attitudes, beliefs, and values of the participants (Strivastava & Thomson, 2009 ).
We used the online qualitative data analysis software Dedoose (2012) to assist the data analysis process. Dedoose was chosen because the online format allowed all of the researchers to work on the analysis using the same data set. We began by developing codes and grouping similar codes into themes. Themes were identified on the basis of patterned responses or meaning within the data set that "capture[d] something important about the data in relation to the research question" (Braun & Clark, 2006, p. 82) . Thus, patterned responses in relation to participants' discussions about why they decided to screen or not to screen, and what influenced screeners to take action and complete the test, were collated.
The analysis initially focused on a priori issues based on the interview guides (such as "risk perception" and "influence of others"). After further exploration, a number of emergent themes were identified, such as "wanting to know," "ambiguity," and "self-care," which were incorporated into the thematic framework. The development of the initial codes and themes was carried out by one of the authors who was not involved in the randomized controlled trial, and who had no previous knowledge or experience with CRC or screening. Once the thematic framework was identified, indexing of the codes was undertaken.
At this stage, the decision was made to test the reliability of the coding framework using the multirater Kappa measure of agreement through the facilities made available by Dedoose (2012) . We recognized that the concept of interrater reliability is a controversial one in qualitative research (Pope, Ziebland, & Mays, 2000) , particularly regarding concerns that a reliability assessment of a predefined list of themes will limit the inductive nature of data analysis by closing the process to additional induction once a coding framework is confirmed (Cook, 2011) . However, we felt that it was useful to check that we all understood what the initial codes were representing and that there was consistency in how we interpreted the participants' comments.
To test for interrater reliability, four interviews were indexed using the coding framework, and the same interviews were then independently indexed by two others using the same coding framework. Kappa scores of 0.96 and 0.98 were achieved, showing good interrater reliability. Differences were discussed and any issues with the coding were resolved before the rest of the transcripts were coded. We were mindful of the importance of the induction process continuing throughout the analysis, and the codes were refined and reorganized as the analysis process continued.
Once the interview transcripts were coded, we charted the themes and undertook the final stage of mapping and interpretation. All of the authors were involved in the analysis, and meetings were held to discuss the themes and resolve issues using the charts as a visual display of participants' views. To help with the final stage of the analysis, we followed Braun and Clarke's (2006) suggestion of asking a number of questions of the data, such as: What does this theme mean? What assumptions underpin it? What are the implications of this theme? What conditions might have given rise to it? Why do people talk about this thing in this particular way (as opposed to other ways)? What is the overall story that the different themes reveal about the topic? Rigor A number of processes were used to ensure analytic rigor (Shenton, 2004) , including the use of both interview and focus group methods of data collection, negative case analysis, frequent debriefing sessions to discuss the analysis, and ensuring the involvement of researchers with no previous knowledge of and experience with CRC and screening. We included both screeners and nonscreeners in the research to ensure a variety of perspectives on decision making regarding screening. We have described the context of the research and detailed the methods of data collection and analysis. We present a rich description of the analysis below, using multiple examples from the interview transcripts and ensuring that the views of all participants are represented.
Results
Nearly all of the participants (98%) decided to screen for CRC in response to the invitation to participate in the randomized controlled trial, although not all of the participants (32% nonscreeners) followed through on this decision. We begin with a discussion of the decision to screen for CRC, followed by an exploration of what motivated the screeners to follow through on their decision. Participants' screening status is included with quotations, with "S" referring to screeners and "NS" referring to nonscreeners.
The Decision to Screen for CRC
The participants discussed a range of reasons for making the decision to screen for CRC. Underlying these, we found a central thread running through the discussions, namely wanting to know their CRC status. We begin with a discussion of the concept of "wanting to know," in which we present respondents' views of why they agreed to be sent the FIT and screen for CRC. We then explore the notion of ambivalence.
Wanting to know. Both screeners and nonscreeners discussed the value of screening in terms of providing them with knowledge of their CRC status. More specifically, although the participants generally understood that the FIT was only the first step in the process to diagnosis, they described the FIT as a means to find out whether or not they had bowel cancer. One of the focus group participants commented, "It was for my own wanting to know if I've got it [CRC]" (S). Screening with the FIT was described as a "safety check" (S), a way of checking on their health status while they still felt healthy: "My health is pretty good at the moment. As I say, it just helps you to know what's going on with your body" (S).
Wanting to know their CRC status extended to participants' thoughts about how they might respond to the results. Although many participants discussed feeling concerned or anxious about the results (one of the barriers to screening identified in the research literature), the majority reported that they would rather know than not know, irrespective of whether the results were positive or negative. Wanting to know was also described as overcoming concerns about the test itself, which involves taking a sample of feces. Some participants were concerned about doing the FIT because they found the test "gross" (NS) or did not like the idea of "playing with poo [fecal matter]" (NS)another reported barrier to screening. However, for the most part, the participants were able to overcome their discomfort because they wanted to know their CRC status.
The participants outlined two advantages of knowing their CRC status. First, if the results were negative for blood, the FIT was seen to offer reassurance by indicating that they did not have CRC: "It's nice to know I'm clear for a few years anyway" (S). Second, if the result was positive for blood, the FIT was described as providing early detection to improve participants' chances of survival if they did have CRC. One participant said, "No one wants to know they've got cancer, but I think most of us would want to know as soon as possible so something, if possible, can be done" (S).
Not wanting to know. The participants also discussed not wanting to know in relation to CRC. In most cases, they were hypothesizing about why other people might decide not to screen. For example, in response to a friend's decision not to screen for cancer, a participant stated, "It's difficult because that's her right. It's her right not to know" (NS). Another participant stated, "And the disadvantage [of screening] for some people-not for me, but for some people-is that they really don't want to know" (NS).
Only two nonscreeners identified that they would rather not know their CRC status, and this was their primary reason for deciding not to complete the FIT. They were mainly concerned about what might happen in the aftermath of finding out they have CRC, particularly regarding treatment. For one nonscreener, her decision not to know related to her experience of watching her mother die of cervical cancer: I don't participate in any type of screening. . . . I watched my mother die an absolutely horrible death as a result of all the treatment she had for cervical cancer, and I vowed and declared at that time that I would rather not know about it, thank you very much. (NS) The other participant expressed similar concerns about negative effects of cancer treatment. These two nonscreeners were unusual in their discussion of not wanting to know their CRC status. The majority of participants, including nonscreeners, wanted to know and made the decision to do the FIT. Given the centrality of wanting to know as expressed by the participants, this raises the question of what underpinned their desire. We found that notions of self-care and the importance of taking personal responsibility for their health underpinned wanting to know.
Screening as self-care. Both screeners and nonscreeners described CRC screening as a form of self-care, and the participants viewed themselves as being health-conscious individuals who took care of their health. Screening for CRC and other cancers also allowed the participants to take personal responsibility for their health. The importance of taking personal responsibility for their health was reinforced by the insistence that the decision to test for CRC was a personal decision-an "individual thing" (S)-rather than relying on the expectations of others, such as family or peers. The view that other people have no influence on the decision to screen for CRC was expressed quite strongly by nearly all of the participants.
Health professionals were also not considered a major influence on participants' decision to screen. Participants discussed how they had made the decision even though their doctors had not suggested that they do the FIT: "I haven't spoken to a health person at all, I've just put a decision on myself for whatever reason to say yes" (S). In fact, some participants stated that they had done the FIT despite their doctor suggesting that they should not do the test: I asked my doctor. She said, "No, you haven't got a history," blah, blah, blah. However, you know, I heard around of friends having . . . bowel cancer and I wanted to do it. So it was really my decision. (S) Ambivalence about the screening decision. As noted, nearly all of the participants made the decision to receive a FIT to screen for CRC because they wanted to know their CRC status; however, we found that in most cases, the desire to know was not expressed as an important or urgent desire. Only a few participants expressed a strong conviction about wanting to know whether they had CRC: "Not knowing is not . . . really an option, in my opinion" (S). Similarly, not wanting to know was a desire strongly expressed by only two nonscreeners. For the majority of participants, the decision to do the test was expressed in ambivalent 1 terms, such as, "Why not?" (S). "There's no real reason not to" (S). "It doesn't hurt to screen" (S). One nonscreener explained her decision to do the FIT in similarly ambivalent terms: "I just thought it would be nice to know that you haven't got a problem down in your bowels.". It appears, therefore, that wanting to know did not function simply on an either-or basis, with screeners wanting to know and nonscreeners not wanting to know their CRC status. Instead, we propose that wanting to know operated on a continuum based on the strength of participants' convictions. This continuum ranged from a strong conviction about wanting to know (it was extremely important to find out their CRC status), to a more ambivalent position (being prepared to engage in screening but not necessarily considering it important), to a strong conviction about not wanting to know. For participants with a strong desire to know, following through on the decision to screen was relatively easy, whereas for those who expressed varying degrees of ambivalence, the ability to follow intention with action was more difficult.
Ambivalence and procrastination. Ambivalence in the screening decision was reflected in procrastination about following through on the decision to screen. A few nonscreeners were unable to do the test because of significant life events (such as caring for a dying relative) or having a colonoscopy (negating the need for the FIT); however, procrastination was the main reason given by nonscreeners for not taking action despite making the decision to screen. For example, one nonscreener who had been overseas periodically during the period of the randomized controlled trial initially gave this as his reason for not doing the FIT, but then went on to state, "It should have been a matter of urgency. I must have a degree of procrastination in me not to seize the moment in between those trips and get this done." Similarly, one of the focus group participants initially stated that her reason for not following through on her decision to screen was that she was caring for a friend who subsequently died of CRC, and that she was then busy and sick. She went on to say, "Actually, that's probably not true. It's probably due to that, 'Come on, you know you're supposed to have had one,' so yeah."
Procrastination was an also an issue for screeners. In fact, taking immediate action following the decision to screen was a straightforward process for only a few of the screeners, whose desire to know their CRC status was strong enough for them to make screening a priority. For the majority, however, there was a degree of procrastination involved before they were able to prioritize the test: "No, I didn't do it quickly. I put it on the side and thought I'd do it later, and then I think I got a reminder that I hadn't done it and so then I did it." Some screeners had procrastinated about testing in the past, describing how they still had unused FOBTs in their cupboards that had been given to them by their doctors.
Ambivalence and risk perception. Risk perception played an important role in participants' levels of conviction about wanting to know their CRC status. Risk was discussed in terms of age, having a family history of bowel cancer, and having a personal history of other forms of cancer. Some participants saw themselves as being at risk for CRC: "Yeah, I'm in that sort of age group that's more likely than not [to get CRC]" (S). Some expressed ambivalence regarding whether or not they were at risk; for example, discussing an absence of risk factors and stating, "But you never know" (S), or, "But that doesn't mean anything, I suppose" (NS). Others did not see themselves as being at risk, or they described mitigating factors that lessened their perceived risk, such as leading a healthy lifestyle, eating well, and having a positive attitude. One participant expressed this belief as, "Well I'm certainly more aware of [CRC] , and I take care of myself in a better way. I look after my diet. I keep myself relatively healthy" (S).
A lack of perceived risk or ambivalence about risk reduced the importance of screening for participants despite agreeing to do the FIT: "I guess if I was worried about my health that would motivate me to move it up my list of jobs to do. But that's not really a big factor" (NS). However, even for those who viewed themselves to be at risk, ambivalence was still evident. For example, a woman whose sister died of CRC explained her decision to screen as follows:
Oh I think [screening is] very advantageous, because as I said, there's so many cancers going around and you never know what you've got. My sister died of colon cancer, so you think, "Well cancer's in the family; it doesn't hurt [to screen]."
Here we see a lack of conviction or certainty about the decision, despite having a family history of CRC, which is evident by the phrase "it doesn't hurt [to screen]." A nonscreener described the importance of screening because of her family history, but she still did not follow through on the decision to screen: "Because I am a cancer sufferer . . . I was very interested in completing this bowel cancer screening, because my mother actually died of bowel cancer." This suggests that awareness of risk factors might not be enough of a motivator to overcome ambivalence toward screening and move some people from intention to action.
Overall, it was interesting to note that, although there was an awareness of the risk factors associated with CRC, particularly in terms of age, diet, and family history, these were not necessarily seen as personally relevant. This can be seen in the example of a screener who perceived her risks of CRC as being "similar to all women. . . . I don't really worry about it, it doesn't stress me on a day-to-day basis," despite having a family history of CRC. Age was another risk factor that was not necessarily viewed as personally relevant. For example, in one of the focus groups the discussion turned to an item on the questionnaire 2 relating to perceived risk and how the participants rated their risk of CRC: I have to say I answered no to one of those [questions] . I think it was the question, "Do you think you're in a high-risk group from getting bowel cancer?" No, other than being over fifty. And I mean, that's the whole world that's over fifty, so that's not a high-risk group, that's everybody. So my answer was no. (NS) This lack of personal relevance in relation to risk might have played a role in participants' ambivalence toward screening.
Another factor in the relationship between ambivalence and risk perception is that instead of focusing specifically on their risk of CRC, the participants more often expressed their risk in terms of a generalized risk of cancer. For example, in the discussions of age as a risk factor, the participants discussed the need to test for many diseases as one ages, with bowel screening another one to add to the list. When discussing their cancer risks, the participants expressed the views that cancer is "all a part of our history and biology of the human body" (NS): "It is so common nowadays" (S). It "is a part of life" (S). "I think probably everybody is aware that cancer can happen to anybody" (S).
For some, this perception of cancer being prevalent fostered a desire to know their CRC status; however, it had the opposite effect on 2 nonscreeners who expressed a more fatalistic view about their risk of cancer: I never give [my risk of cancer] a great deal of consideration. I just think it won't happen to me. And if it does then it was meant to be, and let's just hope it's fast and sharp and, a fatalistic view, I guess. (NS)
The world is full of chances; you have to take chances as they come. . . . It might happen to you, it might not. You don't know. It's just like winning Lotto [the lottery], isn't it? (NS) This highlights the complexity of risk perception in participants' decisions about whether or not to screen for CRC and the lack of a sense of urgency or importance in relation to CRC risk and screening.
The participants discussed a number of influences on their perception of risk for CRC and the personal relevance of risk factors. The most common was personally knowing or hearing about someone who had bowel cancer, which was described as highlighting the importance of screening and thus decreasing ambivalence. The media also influenced participants' risk perceptions, as revealed in the following extract: "My doctor's never suggested I have [a FIT] either, so if it's not coming from the general media, newspaper, TV, or radio then . . . the awareness isn't there" (S). The media was even influential in persuading the participant who stated that she did not want to know her CRC status (because she watched her mother die of cancer) to do the FIT: "In hindsight it was the wrong decision to make. When I read the follow-up data on the TV and newspaper, I felt that it was very remiss of me not to have done [the FIT]" (NS). In this case, the media portrayal of the importance of screening for CRC moved the participant toward wanting to know.
We have proposed that ambivalence toward screening is one possible explanation for the fact that, although both screeners and nonscreeners had decided to screen, not everyone followed through and did the FIT; that is, screening for CRC was not considered important or relevant enough to make it a priority. This raises the question of what is required for individuals to follow through on their decision to screen and take action, particularly because there is evidence that a medium-to-large change in intention only leads to a small-to-medium change in behavior (Webb & Sheeran, 2006) . Researchers have identified cues to action-stimuli that help bridge the gap between intention and behavior-as critical to the transformation of intention to action (Flight, Wilson, & McGillivray, 2012) . In the next section we address the second focus of our analysis, namely an exploration of what motivated the screeners to follow through on their decision despite their apparent ambivalence.
Taking Action
In participants' discussions we identified three cues to action that motivated the screeners to follow through on their decision to screen: convenience, opportunistic screening, and making a commitment to follow through on the decision. These cues appeared to be effective because they supported participants in undergoing screening despite a lack of conviction about wanting to know their CRC status.
Convenience and opportunistic screening. For the participants who followed through with the FIT despite expressing ambivalence toward screening, an important cue to action was being given the chance to screen in a way that caused them the least inconvenience: "It was free and it was being done for me, so I didn't kind of have to head off to the doctor or anything like that. And it was actually being set up for me." The importance of the FIT being free and sent to people's homes, rather than them going to a doctor or pharmacy to get a test, was discussed at some length in the focus groups. Being given the opportunity to screen through participation in a screening program or research study was another cue to action for the participants. Some spoke of wanting to do the FIT before the invitation to participate in the randomized controlled trial but not following through and getting the kit themselves. Therefore, being invited to participate in the study was a good opportunity for them to do the FIT: I seized the opportunity when I got it because . . . I was hoping that I would get one [through the national screening program]. But I didn't actually go to my doctor and say, "I think I should have a test at my age because I've never had one." (S) Another participant stated, "I heard that [the Australian government was] going to stop the testing, and so I thought this was an opportunity to get tested before they stop. Just the opportunity was there so I decided to take it" (S). That is, whereas the participants might have wanted to know their CRC status, the desire to know was not strong enough for them to seek out a screening test, and they indicated that they would rather wait for the opportunity to present itself. In fact, nearly all of the nonscreeners expressed the desire to do the test but were noncommittal when told they could get a test from their doctor or pharmacy rather than wait for another opportunity to come their way.
The emphasis on convenience and opportunistic screening was evident even when participants perceived themselves to be at risk and viewed screening as an important part of taking responsibility for their health. Similarly, participants who had previously screened for CRC (generally through the Australian government's screening program) and who wanted to participate in ongoing screening viewed receiving the FIT as a useful reminder of the need to continue to screen: "I mean it's the second time I've done it. I got one for my fifty-fifth birthday-bowel testing, thank you very much. . . . And thank you for giving me a nudge to do it again." The same participant discussed how ease of access (by being sent a screening test through a government-funded screening program) helps people in "getting over the hurdle of actually getting yourself a kit, working out how to do it, and doing it."
All participants had been given a convenient opportunity to screen by being sent a free FIT through participation in the randomized controlled trial; however, not all of them followed through on their decision to screen. We propose that, because of ambivalence toward CRC screening, it might take time for CRC screening to become a priority in people's lives, highlighting the importance of being given the opportunity to screen in an ongoing manner. This is also supported by the fact that some participants had been provided with screening tests by their doctors but had not used the tests: "I had received a kit before and never used it. I just left it in the cupboard, but when this came along I thought yes, I'll do it" (S).
Making the commitment to screen. The final cue that helped transform participants' intentions into action was making a commitment to do the FIT through participation in the randomized controlled trial. This came up particularly in the focus groups, in which the participants discussed the effect of going through the questionnaire on the study's Web site, which had to be completed prior to the FIT being sent to them. It appears that taking the time to engage with the Web site acted to both reinforce the decision to screen (which they described as having been made as soon as they received the invitation to participate in the study) and to bring the test itself closer to the top of their priority list: Engaging with the Web site was described as making a commitment to follow through and complete the test: "Well I made a commitment. I'll go ahead with it" (S). The value of the Web site as a cue to action is also supported by some of the results of the randomized controlled trial (which will be reported elsewhere), in which it was found that those participants who were allocated to the Web-based version of the questionnaires and information sheets were more likely to complete the FIT than those who were allocated to the paper-based version.
Discussion
We identified the main reason for participants deciding to screen for CRC as wanting to know their CRC status. Previous research on the decision to screen for cancer has also identified the importance of wanting to know, or not wanting to know, in making this decision. For example, in their survey of the factors that influence screening compliance, Arveux et al. (1992) found that the main reason for not participating in CRC screening was "not wanting to know more about their health status" (p. 574). At the other end of the spectrum, in a qualitative study of women's understanding and experience of dual-energy X-ray absorptiometer (DEXA) scanning for osteoporosis, Richardson, Hassell, Hay, and Thomas (2002) found that knowing one's risk status was "central to participants' reasoning about DEXA scans" (p. 122).
Self-care and taking personal responsibility for health were important considerations in relation to the decision to screen. This has been found in previous research on CRC screening (Chapple et al., 2008; Lipworth, Davey, Carter, Hooker, & Hu, 2010; Molina-Barcelo et al., 2011) . It is also consistent with social theories related to late modernity, wherein self-management and the individualization of responsibility have been recognized as central concepts in Western industrialized societies (Crawford, 2006; Crawshaw, 2012) . However, our research has identified that wanting to know one's cancer status might not necessarily be a simple yes-or-no decision; rather, it functions on a continuum ranging from wanting to know, through varying degrees of ambivalence, to not wanting to know.
Only a few of the participants in our study expressed strong views on wanting to know or not wanting to know their CRC status, with the majority demonstrating an overall ambivalence regarding CRC screening, despite an awareness of CRC risk factors. Ambivalence was seen in the participants' lack of conviction about the importance of screening and in their procrastination once the decision was made. Ambivalence in the decision to screen for cancer has been reported in other articles (Knops-Dullens, de Vries, & de Vries, 2007; Lipkus & Klein, 2006; Polzer, Mercer, & Goel, 2002) . For example, Halabi et al. (2000) found that women who were off schedule for a mammography were more likely to be ambivalent toward screening. The women in Willis' (2008) study of mammography screening in Sweden also expressed ambivalence in the decision to attend a mammography.
The ambivalence expressed by the participants in our study might result from the Australian political and cultural context, in which CRC screening is not given a high priority by government or health professionals; in fact, some participants reported that their doctor had told them they did not need to screen for CRC. It might also be a result of the 2-step screening process adopted in Australia, in which individuals test for CRC risk using a FIT, followed by a colonoscopy. Additional research is needed to explore this insight.
Participants indicated ambivalence relating to both the decision to screen for CRC and their risk perception regarding CRC. Similarly, in Willis' (2008) study of women's participation in mammography screening, ambivalence in risk perception was also reported. Researchers and commentators have pointed to the important role played by ambivalence in the individual's response to risk in general (Beck, 2006; Lupton & Tulloch, 2002) . For example, Lupton and Tulloch explored the risk epistemologies of a group of Australians and found that contradiction, ambivalence, and complexity were apparent in participants' accounts of their understandings and experiences of risk. Indeed, Beck stated, "Risk is ambivalence" (p. 331). Our article adds support to the relationship between risk perception and ambivalence.
An important issue relating to risk and ambivalence is the extent to which individuals view risk information as personally relevant (Lipworth et al., 2010) . For example, in Mesters, Ausems, and de Vries' (2005) study of the public's knowledge, interest, and information needs related to genetic cancer, the authors found that "[n]ot being able to estimate the personal relevance of genetic information created feelings of ambivalence, which left most people undecided regarding exposing themselves to genetic information" (p. 72). According to Craddock Lee (2010), "risk information is rarely taken up as valueneutral objective truth, but . . . is deeply subjective, interiorized against a preexisting sense of self" (p. 106). He viewed this translation of risk information as central to understanding ambivalence toward public health efforts such as screening.
The ambivalence expressed by participants might explain why they did not all follow through on their decision to do the FIT. Similarly, Costanza et al. (2009) stated that the intention to screen when not coupled with action (in the form of scheduling a mammography, in their research) "belies an underlying ambivalence or persistent procrastination" (p. 347). This suggests that ambivalence might have played a role in moderating the relationship between participants' intentions and behaviors, so that participants who were more certain about wanting to know their CRC status were more likely to follow through on their intention to screen, and vice versa.
Research on the relationship between ambivalence, attitudes, intention, and screening behavior has demonstrated a similar effect. For example, Connor et al. (2002) found that attitudes toward healthy eating were more predictive of healthy eating behaviors when ambivalence was lower. Dormandy, Hankins, and Marteau (2006) explored the moderating role of ambivalence in the attitude toward and uptake of a prenatal screening test for Down syndrome. They concluded that ambivalence might undermine informed decision making about screening.
Researchers of barriers to CRC screening have identified a range of barriers, but ambivalence has not been specifically discussed in their articles. It is possible that ambivalence underpins these barriers, as found in this study. Potential barriers, such as finding the test unpleasant or fear of the results, were overcome by the participants' strong desires to know their CRC status, but a more ambivalent attitude resulted in procrastination, which was identified as the main reason for not completing the FIT. Previous research has also identified procrastination as a major barrier to CRC screening (Janz et al., 2007; Vernon, 1997; Worthley et al., 2006) . The relationship between ambivalence and procrastination in CRC screening should be explored further.
Previous research has identified that changing behavioral intentions does not necessarily engender behavior change (Webb & Sheeran, 2006) , and it has highlighted the importance of exploring and understanding cues to action. Given their ambivalence regarding wanting to know their CRC status and procrastination in following through on the decision to screen, the main cue to action for participants in our study was the opportunity to screen without being too inconvenienced. Similarly, calling women to mammography screening and ease of attendance were identified in Willis' (2008) study as important in overcoming women's ambivalence toward screening without being coercive. These findings highlight the importance of providing ongoing, convenient (and free) screening opportunities for target populations. The results are perhaps a reflection of the Australian health care system, which provides free access to screening for a range of cancers. This might lead to the expectation that screening should be free and initiated by the government.
Another cue to action was committing to do the FIT through engagement with the Web site as part of participants' involvement in the randomized controlled trial. The role of personal commitment and commitment to others has been identified as an important factor in moving people from intention to action (Ajzen, Czach, & Flood, 2009 ). For example, Elley, Dean, and Kerse (2009) found that both types of commitment motivated people to engage in physical activity.
In our study, the participants were keen to emphasize that the decision to screen with the FIT was their decision and was not influenced by others, including health care professionals. This contrasts with previous research, which highlighted the importance of recommendations from health care professionals in the decision to screen for CRC (Costanza et al., 2005; Vedel et al., 2011; Zajac et al., 2010) . However, participants identified indirect influences on their decision to screen, such as knowing others with CRC and media reports on the topic. This suggests opportunities to noncoercively influence people's decisions regarding CRC screening in terms of indirect influences such as the media.
Limitations
This was a qualitative, exploratory study and, as such, the findings are limited in terms of generalizability. More screeners than nonscreeners participated in the study, and people who felt strongly about not participating in CRC screening might not have wanted to be interviewed. Furthermore, because participants were selected from participants in a randomized controlled trial evaluating a decision support tool for CRC screening, this could have created a bias toward wanting to know their CRC status. Additional research needs to be conducted to explore the extent to which these findings are applicable more generally, and particularly in other countries, given the differences in health systems and approaches to screening.
Conclusion
This article builds on existing literature on the decision to screen for CRC by exploring why people who were offered the FIT decided to screen or not to screen, and what influenced some of them to take action and complete the test. The results highlight the complex relationship between risk perception and screening behavior, demonstrating ambivalence toward screening among both screeners and nonscreeners. This suggests that unless individuals have a sense of personal risk for CRC, screening opportunities will need to be as accessible and convenient as possible.
